Mechanisms of Commensal- Specific CD8+ T Cell Differentiation, Restraint and Dysregulation in Intestinal Inflammation

What To Know

This is an NIH-funded project record describing laboratory research into how CD8+ T cells that recognize commensal gut microbes develop, are normally restrained, and become dysregulated in inflammatory bowel disease (IBD), with a focus on ulcerative colitis.

The investigators will use murine models and molecular approaches to identify antigen-presenting cells, cell-intrinsic pathways that control intraepithelial CD8+ T cells, and the origins of pathogenic KLRG1+Eomes+ CD8+ T cells in colitis.

The summary emphasizes basic-science aims rather than clinical results: it frames the work as mechanistic research intended to reveal potential therapeutic targets by improving understanding of commensal-specific CD8+ T cell biology and how loss of restraint may contribute to intestinal inflammation.

The record reports funded specific aims and preclinical approaches (mouse models, cellular and molecular studies) but does not present patient-facing findings, treatment effects, or clinical recommendations. It is best read as translational lab research that could inform future therapies if later validated.